Effects of Clopidogrel on the Anticonvulsant Efficacy of Valproic Acid and Levetiracetam in a PTZ-Induced Seizure Model
International Journal of Molecular Sciences · 19.07.2026 · 27 (14) · 6415
DOI: 10.3390/ijms27146415 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.07.2026. Verfasst von Sibel Özdemir und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Yunus Emre State Hospital, Eskişehir 26140, Türkiye. Hauptthemen laut MEDLINE: Levetiracetam, Valproic Acid, Clopidogrel, Anticonvulsants. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sivas Cumhuriyet University, Cumhuriyet University Scientific Research Projects.
Abstract (Originalsprache)
Patients with cerebrovascular disease frequently require concomitant antiplatelet and antiseizure therapy. However, experimental evidence regarding potential pharmacodynamic interactions between these medications remains limited. The present study investigated whether clopidogrel affects the anticonvulsant effects of valproic acid (VPA) or levetiracetam (LEV) in a pentylenetetrazol (PTZ)-induced seizure model. Forty-two male Wistar rats were randomly allocated to seven groups (n = 6/group): Control, PTZ, clopidogrel (CLP), VPA, LEV, VPA + CLP + PTZ, and LEV + CLP + PTZ. Electroencephalographic recordings, passive avoidance testing, histopathological examination, and glial fibrillary acidic protein (GFAP) immunohistochemistry were performed to evaluate seizure activity, behavioral performance, neuronal injury, and astroglial activation. Both VPA and LEV significantly reduced spike–wave discharge frequency and duration compared with the PTZ group (p < 0.05). Clopidogrel alone did not exhibit anticonvulsant activity, and co-administration with either VPA or LEV did not significantly alter electrophysiological, behavioral, histopathological, or GFAP-associated immunohistochemical outcomes. Overall, these findings indicate that clopidogrel did not significantly affect the anticonvulsant efficacy of VPA or LEV under the experimental conditions of this acute PTZ-induced seizure model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Yunus Emre State Hospital, Eskişehir 26140, Türkiye.
- Department of Neurology, Faculty of Medicine, Cumhuriyet University, Sivas 58140, Türkiye.
- Department of Histology & Embryology, Faculty of Medicine, Cumhuriyet University, Sivas 58140, Türkiye.
ORCID-Profile: Sibel Özdemir
Förderung
- Sivas Cumhuriyet University
- Cumhuriyet University Scientific Research Projects
Zitieren
APA
Özdemir, S., Bolayir, E., & Şahin İnan, Z. D. (2026). Effects of Clopidogrel on the Anticonvulsant Efficacy of Valproic Acid and Levetiracetam in a PTZ-Induced Seizure Model. International Journal of Molecular Sciences, 27(14), 6415. https://doi.org/10.3390/ijms27146415
Vancouver
Özdemir S, Bolayir E, Şahin İnan ZD. Effects of Clopidogrel on the Anticonvulsant Efficacy of Valproic Acid and Levetiracetam in a PTZ-Induced Seizure Model. International Journal of Molecular Sciences. 2026;27(14):6415. doi:10.3390/ijms27146415
BibTeX
@article{zdemir2026,
author = {Özdemir, Sibel and Bolayir, Ertugrul and Şahin İnan, Zeynep Deniz},
title = {Effects of Clopidogrel on the Anticonvulsant Efficacy of Valproic Acid and Levetiracetam in a PTZ-Induced Seizure Model},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6415},
doi = {10.3390/ijms27146415}
}
EUVIMED